Health Tech Capitol | FCDI Launches iCell Microglia
16544
post-template-default,single,single-post,postid-16544,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

FCDI Launches iCell Microglia

08 Jan FCDI Launches iCell Microglia

Posted at 11:50h in Uncategorized by
0 Likes

FUJIFILM Cellular Dynamics Inc. (FCDI) has launched iCell Microglia, the company announced today.

According to a release, iCell Microglia will be used in life science research to enable the study and development of therapies for degenerative neurological diseases such as Alzheimer’s disease.

“As human iPSC derived-cells provide a more relevant biology than current animal models in preclinical trials, iCell Microglia can help researchers gain a greater understanding of the nature of neurological diseases and how to treat the diseases,” FCDI CEO Seimi Satake said in a statement.

Read more at Madison Startups

No Comments

Sorry, the comment form is closed at this time.